Intervention not reported
All‐cause mortality at day 28 · hospitalized people with mild to moderate symptomatic COVID‐19 (WHO scale 2 to 4) with severe comorbidities
It is very uncertain whether the intervention changes all‐cause mortality at day 28 (very low certainty).
1 finding from 1 review
- Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19 2023 · Cochrane Headline outcomes onlyRR 0.63 [0.21, 1.86]1 study · 264 participantsVery low